Nachrichten zur Bristol-Myers Squibb Co Aktie

Bristol-Myers and BioMotiv launch new drug venture

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Bristol-Myers Opdivo-Yervoy NSCLC Application in EU Withdrawn

Bristol-Myers (BMY) has withdrawn its application in the EU for the Opdivo and Yervoy combo for the treatment of advanced…

Factors Setting the Tone for Bristol-Myers (BMY) Q4 Earnings

Investors will focus on regular top and bottom-line numbers along with key pipeline updates when Bristol-Myers (BMY) reports fourth-quarter results....…

The Week Ahead In Biotech: Merck, Bristol-Myers Earnings, Conference Presentations In Focus

Biotech stocks see-sawed through the week ended Jan. 31 and ended the month lower overall. Big pharma earnings of the…

Bristol-Myers Withdraws European Application for Lung Cancer Combo

Regulators said its impossible to evaluate the drug with so many clinical trial alterations....…

UPDATE 2-Bristol-Myers pulls Opdivo+Yervoy lung application in Europe

Drugmaker Bristol-Myers Squibb Co said on Friday it was pulling the application to have its immunotherapies Opdivo and Yervoy approved in Europe…

CORRECTED-UPDATE 1-Bristol-Myers Squibb pulls Opdivo+Yervoy lung application in Europe

Drugmaker Bristol-Myers Squibb Co said on Friday it was pulling the application to have its immunotherapies Opdivo and Yervoy approved in Europe…

CORRECTED-Bristol-Myers pulls Opdivo+Yervoy lung application in Europe

Drugmaker Bristol-Myers Squibb Co said on Friday it was pulling the application to have its immunotherapies Opdivo and Yervoy approved in Europe…

Bristol-Myers Squibb withdraws European application for O+Y for lung cancer

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Bristol-Myers pulls Opdivo+Yervoy lung application in Europe

Drugmaker Bristol Myers Inc said on Friday it was pulling the application to have its immunotherapies Opdivo and Yervoy approved in Europe…

UPDATE 1-Bristol-Myers pulls Opdivo+Yervoy lung application in Europe

Drugmaker Bristol Myers Inc said on Friday it was pulling the application to have its immunotherapies Opdivo and Yervoy approved in Europe…

ServiceNow CEO Bill McDermott talks earnings results and 2020 guidance

John Donahoe, ServiceNow CEO, discusses the company's quarterly earnings, first-quarter guidance, taking on new customers such as Bristol-Myers Squibb and…

3 Stocks With Rising Prices That Still Look Cheap

A search for healthy companies bucking the trend toward high P/Es turned up only a handful of names. How Discovery,…

Bristol-Myers Squibb (BMY) Outpaces Stock Market Gains: What You Should Know

Bristol-Myers Squibb (BMY) closed the most recent trading day at $64.81, moving +1.74% from the previous trading session....…

Bristol-Myers: A Blue Chip Name Worth Buying During the Coronavirus Scare

Um den gesamten Artikel unter thestreet.com zu lesen, klicken Sie bitte auf die Überschrift...…

Bristol-Myers Squibb: Strong Quality And Attractive Valuation

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Bristol-Myers Squibb is planning to launch 8 drugs in 18 months for everything from cancer to multiple sclerosis. Heres what they are and how the $150 billion pharma giant plans to pull it off.

The newly combined Bristol-Myers Squibb and Celgene is shaping up to be a formidable company in the pharmaceutical industry. Its now…

An Emboldened Bristol-Myers Squibb Wants $1.5 Billion From Gilead Sciences

A jury that told Gilead Sciences to pay $752 million worth of patent infringement damages didnt go as far as…

Here is Why Growth Investors Should Buy Bristol-Myers (BMY) Now

Bristol-Myers (BMY) could produce exceptional returns because of its solid growth attributes....…

Bristol-Myers Squibb: The Merger Is Complete, Time To Shine

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

How Does Bristol-Myers Squibbs Revenue And Other Key Metrics Compare With That of Merck-

Bristol-Myers Squibb and Merck primarily serve the pharmaceuticals products markets. The companies discover, develop, and sell pharmaceutical products globally. Their…

Stocks to Watch: UBS, Delta, American Airlines, Pfizer

UBS, Delta, American Airlines, Pfizer and Bristol-Myers Squibb are among the companies with shares expected to trade actively Tuesday....…

Should Value Investors Buy Bristol-Myers Squibb (BMY) Stock-

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to…

DGAP-News: Evotec SE

EVOTEC UND BRISTOL-MYERS SQUIBB ERWEITEREN IPSC-ALLIANZ...…

Evotec erhält Millionenzahlung - Aktie nimmt wieder Fahrt auf

Der Wirkstoffforscher Evotec kann sich im Zuge einer erweiterten Zusammenarbeit mit dem Pharmakonzern Bristol-Myers Squibb (BMS) über eine Millionenzahlung freuen.…

Is Bristol-Myers Squibb (BMY) a Good Stock to Pick Now-

Is Bristol-Myers Squibb (BMY) a great pick from the value investors perspective right now? Read on to know more....…

Zacks.com featured highlights include: Genesco, GreenTree Hospitality, Bristol-Myers Squibb, Barclays PLC and Valero Energy

Zacks.com featured highlights include: Genesco, GreenTree Hospitality, Bristol-Myers Squibb, Barclays PLC and Valero Energy...…

FDA accepts for priority review Bristol-Myers Squibbs application for Opdivo plus Yervoy in first-line NSCLC

The FDA has granted the application Priority Review with a Prescription Drug User Fee Act (PDUFA) goal date of May…

Cramers lightning round: Swap Pfizer for Bristol-Myers or Abbvie

"Mad Money" host Jim Cramer makes buy and sell calls on Pfizer, Nextera Energy, Axon Enterprise and more stocks....…

FDA sagt Bristol Myers Squibb beschleunigte Prüfung für Krebs-Kombitherapie zu

PRINCETON (dpa-AFX) - Der US-Pharmakonzern Bristol Myers Squibb (Bristol-Myers Squibb) hat in den USA mit seinem wichtigen Krebsmittel Opdivo Aussicht…

FDA sagt Bristol Myers Squibb beschleunigte Prüfung für Krebs-Kombitherapie zu

PRINCETON (dpa-AFX) - Der US-Pharmakonzern Bristol Myers Squibb hat in den USA mit seinem wichtigen…

FDA accepts Bristol-Myers Squibbs application for lung cancer combo

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Bristol-Myers Squibb (BMY) Presents At 38th Annual J.P. Morgan Healthcare Conference - Slideshow

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Bristol-Myers Squibb (BMY) Outpaces Stock Market Gains: What You Should Know

In the latest trading session, Bristol-Myers Squibb (BMY) closed at $66.15, marking a +1.41% move from the previous day....…

Bristol-Myers Squibb Company (BMY) CEO Giovanni Caforio on 38th Annual JP Morgan Healthcare Conference (Transcript)

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Bristol-Myers Squibb CEO on the drug pipeline, 2020 outlook and more

Bristol-Myers Squibb CEO Dr. Giovanni Caforio sits down with CNBC's Jim Cramer at the J.P. Morgan Healthcare Conference in San…

Heres Why Nektar Therapeutics Shares Rose as Much as 19.7% Today

The company announced a new development plan with Bristol-Myers Squibb....…

Nektar Therapeutics, Bristol-Myers Expand Effort to Develop Treatment for Cancer

Um den gesamten Artikel unter thestreet.com zu lesen, klicken Sie bitte auf die Überschrift...…

The Zacks Analyst Blog Highlights: Novartis, McDonalds, Bristol-Myers Squibb, CME and UBS

The Zacks Analyst Blog Highlights: Novartis, McDonalds, Bristol-Myers Squibb, CME and UBS...…

Bristol-Myers Squibb Company (BMY) Presents at Goldman Sachs 12th Annual Healthcare CEOs Unscripted Conference (Transcript)

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Top Analyst Reports for Novartis, McDonalds & Bristol-Myers Squibb

Top Analyst Reports for Novartis, McDonald's & Bristol-Myers Squibb...…

Bristol-Myers Squibbs Celgene Unit Backs Out of a $55 Million Settlement

Not enough defendants were willing to sign onto the class action....…

Bristol-Myers confident of approvals linked to higher Celgene investor payout -Bristol exec

Bristol-Myers Squibb Co is confident it will receive U.S. approvals for all three experimental drugs tied to a potentially higher payout for Celgene…

Evotec: Es regnet Millionen dank Bayer - wieder mal!

Vor zwei Tagen machte Evotec (WKN: 566480) die Erweiterung seiner iPSC-Allianz mit Bristol-Myers Squibb öffentlich (wir berichteten). Heute meldet der…

3 Reasons Growth Investors Will Love Bristol-Myers (BMY)

Bristol-Myers (BMY) possesses solid growth attributes, which could help it handily outperform the market....…

Bristol-Myers and Sanofi fought back against an $8 billion lawsuit filed by Hawaii over marketing of their blockbuster blood-thinning drug Plavix

Um den gesamten Artikel unter trib.al zu lesen, klicken Sie bitte auf die Überschrift...…

Zacks.com featured highlights include: Helen of Troy, Penn National Gaming, Arcos Dorados, Insight Enterprises and Bristol-Myers Squibb

Zacks.com featured highlights include: Helen of Troy, Penn National Gaming, Arcos Dorados, Insight Enterprises and Bristol-Myers Squibb...…